Biocept Inc (BIOC)

$2.05 0.11 (5.09%)

16:00 EDT BIOC Stock Quote Delayed 30 Minutes

Why Is Biocept (BIOC) Stock Down 42% Today?

By William White, InvestorPlace Writer May 25, 2023

Biocept (BIOC) stock is falling hard on Thursday after the company revealed details of a public offering for its shares.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Volume:

Previous Close -

Market Cap 36.46M

PE Ratio -0.96

EPS -2.14

Volume (Avg. Vol.) 106,841

Day's Range $2.05 - $2.20

52-Week Range $0.21 - $13.43

Dividend & Yield N/A (N/A)

BIOC Stock Predictions, Articles, and Biocept Inc News

From InvestorPlace
From the Web

6 F-Rated Penny Stocks Not Worth Your Dime

By Louis Navellier and the InvestorPlace Research Staff Jan 31, 2023

Each earning an "F" rating in Portfolio Grader, the odds are not on your side with these seven penny stocks to sell.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Jan 24, 2023

We're starting the day with a look at the biggest pre-market stock movers traders need to know about on Tuesday morning!

7 of the Best Penny Stocks to Buy Coming Into Year-End

By Muslim Farooque, InvestorPlace Contributor Sep 21, 2021

These penny stocks are undervalued based on their fundamentals and have the potential to break through in the coming months.

Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Wednesday Morning

By William White, InvestorPlace Writer Apr 14, 2021

We're at the midpoint of the week and InvestorPlace.com is taking a look at the biggest pre-market movers for investors to keep an eye on.

7 Penny Stocks Worth the Danger as Pandemic Catalyzes Growth

By Alex Sirois Jul 31, 2020

These seven penny stocks have the right catalysts, business models, and tailwinds. Read about why the risk is worth it.

BIOC: What’s Going on With Biocept Stock?

By Karl Utermohlen, InvestorPlace Writer Jul 13, 2018

Biocept stock (BIOC) was skyrocketing on Friday as the company announced a liquid biopsy testing partnership with Alliance Global FZ.

Peregrine Pharmaceuticals (PPHMP) Leads 14 Activist Investor Reports

By Fintel Apr 20, 2017

Recent 13-D and 13-G filings are a window into activist activity. We look at Peregrine Pharmaceuticals and 13 others

5 Best Stocks Under $5 This Week

By Ethan Roberts, InvestorPlace Contributor Sep 25, 2015

Markets were lackluster this week, but ATA, Jaguar Animal Health, Biocept, Aware and CVSL were all tigers.

5 Best Stocks Under $5 This Week

By Ethan Roberts, InvestorPlace Contributor Apr 24, 2015

The market had a decent week, but Uranium Energy, NF Energy Saving, Biocept, Bovie Medical and Sequans Communications outperformed most of the larger stocks.

5 Best Stocks Under $5 This Week

By Ethan Roberts, InvestorPlace Contributor Feb 27, 2015

A few biotech companies, such as Biocept and Cyclacel Pharmaceuticals, were among the best stocks below $5 this week.

Biocept stock surges on pricing $5.0M stock offering (NASDAQ:BIOC)

From Seeking Alpha May 25, 2023

Biocept (BIOC) has priced an underwritten public offering of 1.18M shares of its common stock and warrants to purchase up to an aggregate of 2.35M shares of its common stock at a...

Biocept stock pops as enrollment starts for cancer test CNSide's trial

From Seeking Alpha Mar 24, 2023

Biocept (BIOC) said the first patient was enrolled in a trial of its cerebrospinal fluid assay CNSide. Read more here

Biocept explores strategic alternatives, to cut workforce by 35% (NASDAQ:BIOC)

From Seeking Alpha Jan 6, 2023

Biocept (BIOC) is exploring strategic alternatives, including a possible M&A and sale of assets, to enhance shareholder value.

Maxim Group Remains a Buy on Biocept (BIOC)

From TipRanks Nov 12, 2022

In a report released yesterday, Jason McCarthy from Maxim Group maintained a Buy rating on Biocept (BIOC – Research Report), with a price target of $4.00. The...

Biocept's Return On Capital Employed Overview

From Benzinga May 24, 2022

According to Benzinga Pro data, during Q1, Biocept (NASDAQ:BIOC) posted sales of $19.95 million. Earnings were up 6.84%, but Biocept still reported an overall loss of $2.77 million.

The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More

From Benzinga May 22, 2022

Biotech stocks advanced in the week ending May 22, defying the broader market retreat. The defensive nature of the industry and stock-specific moves lent support.

Biocept Inc (BIOC)

Why Is Biocept (BIOC) Stock Down 42% Today?

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Biocept Inc (BIOC)

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

BIOC Stock Predictions, Articles, and Biocept Inc News

Subscriber Sign in